U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670455) titled 'Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response' on June 19.
Brief Summary: High-grade gliomas (HGGs) are the most common type of brain cancer in adults. Life expectancy for patients with HGGs is low. Radiotherapy aims to cure the tumour, but this is hard because HGGs are resistant to treatment. Among the possible causes of resistance may be tumour cells with low-oxygen levels (hypoxia). We know this makes tumours less sensitive to radiotherapy. Using a special imaging technique called oxygen-enhanced MRI (OE-MRI) we can try to identify areas of the tumour with hypoxia. We co...